The priority review process is for products that have substantial evidence of significant improvements for severe diseases, life-threatening or severely debilitating diseases. Those are the high-level ones.
October 18th, 2012 / 11:50 a.m.
Director General, Therapeutic Products Directorate, Health Products and Food Branch, Department of Health
The priority review process is for products that have substantial evidence of significant improvements for severe diseases, life-threatening or severely debilitating diseases. Those are the high-level ones.
See context to find out what was said next.